Ignite Creation Date:
2025-12-24 @ 9:38 PM
Ignite Modification Date:
2025-12-25 @ 7:21 PM
Study NCT ID:
NCT00604032
Status:
COMPLETED
Last Update Posted:
2008-03-28
First Post:
2008-01-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%
Sponsor:
Coria Laboratories, Ltd.
Organization:
Study Overview
Official Title:
Clinical Evaluation of the Phototoxic Potential of Atralin (Tretinoin) Gel, 0.05%
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: